Camurus AB (CAMX.ST)
CAMX.ST on Stockholm Stock Exchange
102.80SEK
18 May 2018
102.80SEK
18 May 2018
Change (% chg)
0.20kr (+0.19%)
0.20kr (+0.19%)
Prev Close
102.60kr
102.60kr
Open
102.00kr
102.00kr
Day's High
104.00kr
104.00kr
Day's Low
101.40kr
101.40kr
Volume
9,221
9,221
Avg. Vol
38,562
38,562
52-wk High
147.80kr
147.80kr
52-wk Low
91.30kr
91.30kr
About
Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | kr4,585.62 |
| Shares Outstanding(Mil.): | 37.28 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CAMX.ST | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.95 | 32.75 |
| EPS (TTM): | -3.41 | -- | -- |
| ROI: | -23.26 | 14.84 | 14.38 |
| ROE: | -23.26 | 16.34 | 16.07 |
BRIEF-Camurus Q4 Operating Loss Widens To SEK 66.1 Million
* Q4 NET SALES SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago
* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
Estimates